Sentinel Lymph Node Biopsy in Early Stages of Oral Squamous Cell Carcinoma Using the Receptor-Targeted Radiotracer <sup>99m</sup>Tc-Tilmanocept

Sentinel Lymph Node Biopsy in Early Stages of Oral Squamous Cell Carcinoma Using the Receptor-Targeted Radiotracer <sup>99m</sup>Tc-Tilmanocept

Neck management in patients with early-stage, clinically node-negative oral squamous cell carcinoma (OSCC) remains a matter of discussion. Sentinel lymph node biopsy (SLNB) represents a treatment alternative to avoid elective neck dissection (END) in this cohort and different protocols and tracers e...

Full description

Bibliographic Details
Main Authors: Christian Doll, Claudius Steffen, Holger Amthauer, Nadine Thieme, Thomas Elgeti, Kai Huang, Kilian Kreutzer, Steffen Koerdt, Max Heiland, Benedicta Beck-Broichsitter
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Diagnostics
Subjects:
oral squamous cell carcinoma
sentinel lymph node biopsy
neck dissection
radiotracer
tilmanocept
Online Access:https://www.mdpi.com/2075-4418/11/7/1231

Similar Items

Similar Items